Found 0 matching trials
MS-ResearchBiomarkerS
N/AThis study is being conducted to investigate risk factors for disability pr...
Location
Cedars-Sinai Medical Center
A Study of NeuroVax™, a Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis
PHASE2Multi-center, randomized , double-blind, placebo-controlled , two arm paral...
Study to Compare Double-dose Betaferon to the Approved Dose, for Patients With Early Secondary Progressive Multiple Sclerosis (SPMS)
PHASE3The purpose of the study is to evaluate if the higher dose can give greater...
Location
Multiple Locations
Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease
N/AThis study intends to explore evolution of MSRV expression by analyzing the...
Location
Hospices civils de Lyon - Service de Neurologie A - 59 Boulevard Pinel
Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MS
NAThe purpose of this research study is to investigate the effectiveness of a...
Location
Kessler Foundation
Evaluating the Use of Oral Indapamide to Reduce Disabiltiy Progression in Progressive Multiple Sclerosis (MS)
PHASE2The goal of this clinical trial is to determine whether treatment with inda...
Location
Multiple Locations
Functional Electrical Stimulation for Individuals With Secondary Progressive Multiple Sclerosis
NASecondary progressive multiple sclerosis (SPMS) is a subtype of multiple sc...
Location
Johns Hopkins / Kennedy Krieger Institute
Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography
NAThis study aims to:
* analyze prospectively the prevalence of subclinical ...
Location
Centre Mémoire / Centre de Gérontologie Clinique Rainier III / Princess Grace Hospital
RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis
PHASE1RESET-MS: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy ...
Location
Multiple Locations
Masitinib in the Treatment of Patients With Primary Progressive or Non-active Secondary Progressive Multiple Sclerosis
PHASE3To evaluate the efficacy and safety of oral masitinib versus placebo in the...
Location
Service de Neurologie Hôpital Henri-Mondor